Ginsenoside Rh3 Inhibits Lung Cancer Metastasis by Targeting Extracellular Signal-Regulated Kinase: A Network Pharmacology Study

Lung cancer has a high mortality rate and is very common. One of the main reasons for the poor prognosis of patients with lung cancer is the high incidence of metastasis. Ginsenoside Rh3, a rare ginsenoside extracted from Panax notoginseng, exhibits excellent anti-inflammatory and anti-tumor effects...

Full description

Bibliographic Details
Main Authors: Xiaodan Xue, Yannan Liu, Linlin Qu, Cuiying Fan, Xiaoxuan Ma, Pingkai Ouyang, Daidi Fan
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/15/6/758
_version_ 1797483426683551744
author Xiaodan Xue
Yannan Liu
Linlin Qu
Cuiying Fan
Xiaoxuan Ma
Pingkai Ouyang
Daidi Fan
author_facet Xiaodan Xue
Yannan Liu
Linlin Qu
Cuiying Fan
Xiaoxuan Ma
Pingkai Ouyang
Daidi Fan
author_sort Xiaodan Xue
collection DOAJ
description Lung cancer has a high mortality rate and is very common. One of the main reasons for the poor prognosis of patients with lung cancer is the high incidence of metastasis. Ginsenoside Rh3, a rare ginsenoside extracted from Panax notoginseng, exhibits excellent anti-inflammatory and anti-tumor effects. Nonetheless, the inhibitory potential of Rh3 against lung cancer remains unknown. The target genes of Rh3 were screened by the PharmMapper database; the proliferation of lung cancer cells was detected by MTT assay; the migration and invasion of cells were detected by the Transwell method; and the expression of extracellular signal-regulated kinase (ERK) and EMT-related proteins in vivo and in vitro were detected by Western blotting. In addition, we established a lung metastasis model in nude mice using A549 cells to assess the effect of Rh3 on NSCLC tumor metastasis in vivo. Our findings suggest that Rh3 significantly inhibited lung cancer metastasis both in vivo and in vitro. It was determined by flow cytometry analysis that Rh3 notably inhibited cell proliferation by blocking the G1 phase. In addition, Rh3 inhibited metastasis in lung cancer cells and regulated the expression of metastasis-related proteins under hypoxia. Mechanistic studies suggested that Rh3 targeted ERK to inhibit lung cancer metastasis. The ERK inhibitor U0126 or siRNA-mediated knockdown of ERK had an enhanced effect on Rh3’s ability to inhibit lung cancer metastasis. The studies revealed that the inhibitory effect of Rh3 on the metastatic ability of lung cancer cells may be supported by ERK-related signaling pathways.
first_indexed 2024-03-09T22:46:49Z
format Article
id doaj.art-c54b9d4d339b4d7eab34172a12edeae8
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-09T22:46:49Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-c54b9d4d339b4d7eab34172a12edeae82023-11-23T18:28:13ZengMDPI AGPharmaceuticals1424-82472022-06-0115675810.3390/ph15060758Ginsenoside Rh3 Inhibits Lung Cancer Metastasis by Targeting Extracellular Signal-Regulated Kinase: A Network Pharmacology StudyXiaodan Xue0Yannan Liu1Linlin Qu2Cuiying Fan3Xiaoxuan Ma4Pingkai Ouyang5Daidi Fan6Shaanxi Key Laboratory of Degradable Biomedical Materials, School of Chemical Engineering, Northwest University, Taibai North Road 229, Xi’an 710069, ChinaShaanxi Key Laboratory of Degradable Biomedical Materials, School of Chemical Engineering, Northwest University, Taibai North Road 229, Xi’an 710069, ChinaShaanxi Key Laboratory of Degradable Biomedical Materials, School of Chemical Engineering, Northwest University, Taibai North Road 229, Xi’an 710069, ChinaXi’an Giant Biotechnology Co., Ltd., Xi’an 710076, ChinaShaanxi Key Laboratory of Degradable Biomedical Materials, School of Chemical Engineering, Northwest University, Taibai North Road 229, Xi’an 710069, ChinaCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, ChinaShaanxi Key Laboratory of Degradable Biomedical Materials, School of Chemical Engineering, Northwest University, Taibai North Road 229, Xi’an 710069, ChinaLung cancer has a high mortality rate and is very common. One of the main reasons for the poor prognosis of patients with lung cancer is the high incidence of metastasis. Ginsenoside Rh3, a rare ginsenoside extracted from Panax notoginseng, exhibits excellent anti-inflammatory and anti-tumor effects. Nonetheless, the inhibitory potential of Rh3 against lung cancer remains unknown. The target genes of Rh3 were screened by the PharmMapper database; the proliferation of lung cancer cells was detected by MTT assay; the migration and invasion of cells were detected by the Transwell method; and the expression of extracellular signal-regulated kinase (ERK) and EMT-related proteins in vivo and in vitro were detected by Western blotting. In addition, we established a lung metastasis model in nude mice using A549 cells to assess the effect of Rh3 on NSCLC tumor metastasis in vivo. Our findings suggest that Rh3 significantly inhibited lung cancer metastasis both in vivo and in vitro. It was determined by flow cytometry analysis that Rh3 notably inhibited cell proliferation by blocking the G1 phase. In addition, Rh3 inhibited metastasis in lung cancer cells and regulated the expression of metastasis-related proteins under hypoxia. Mechanistic studies suggested that Rh3 targeted ERK to inhibit lung cancer metastasis. The ERK inhibitor U0126 or siRNA-mediated knockdown of ERK had an enhanced effect on Rh3’s ability to inhibit lung cancer metastasis. The studies revealed that the inhibitory effect of Rh3 on the metastatic ability of lung cancer cells may be supported by ERK-related signaling pathways.https://www.mdpi.com/1424-8247/15/6/758ginsenoside Rh3network pharmacologyhuman lung cancermetastasisERK
spellingShingle Xiaodan Xue
Yannan Liu
Linlin Qu
Cuiying Fan
Xiaoxuan Ma
Pingkai Ouyang
Daidi Fan
Ginsenoside Rh3 Inhibits Lung Cancer Metastasis by Targeting Extracellular Signal-Regulated Kinase: A Network Pharmacology Study
Pharmaceuticals
ginsenoside Rh3
network pharmacology
human lung cancer
metastasis
ERK
title Ginsenoside Rh3 Inhibits Lung Cancer Metastasis by Targeting Extracellular Signal-Regulated Kinase: A Network Pharmacology Study
title_full Ginsenoside Rh3 Inhibits Lung Cancer Metastasis by Targeting Extracellular Signal-Regulated Kinase: A Network Pharmacology Study
title_fullStr Ginsenoside Rh3 Inhibits Lung Cancer Metastasis by Targeting Extracellular Signal-Regulated Kinase: A Network Pharmacology Study
title_full_unstemmed Ginsenoside Rh3 Inhibits Lung Cancer Metastasis by Targeting Extracellular Signal-Regulated Kinase: A Network Pharmacology Study
title_short Ginsenoside Rh3 Inhibits Lung Cancer Metastasis by Targeting Extracellular Signal-Regulated Kinase: A Network Pharmacology Study
title_sort ginsenoside rh3 inhibits lung cancer metastasis by targeting extracellular signal regulated kinase a network pharmacology study
topic ginsenoside Rh3
network pharmacology
human lung cancer
metastasis
ERK
url https://www.mdpi.com/1424-8247/15/6/758
work_keys_str_mv AT xiaodanxue ginsenosiderh3inhibitslungcancermetastasisbytargetingextracellularsignalregulatedkinaseanetworkpharmacologystudy
AT yannanliu ginsenosiderh3inhibitslungcancermetastasisbytargetingextracellularsignalregulatedkinaseanetworkpharmacologystudy
AT linlinqu ginsenosiderh3inhibitslungcancermetastasisbytargetingextracellularsignalregulatedkinaseanetworkpharmacologystudy
AT cuiyingfan ginsenosiderh3inhibitslungcancermetastasisbytargetingextracellularsignalregulatedkinaseanetworkpharmacologystudy
AT xiaoxuanma ginsenosiderh3inhibitslungcancermetastasisbytargetingextracellularsignalregulatedkinaseanetworkpharmacologystudy
AT pingkaiouyang ginsenosiderh3inhibitslungcancermetastasisbytargetingextracellularsignalregulatedkinaseanetworkpharmacologystudy
AT daidifan ginsenosiderh3inhibitslungcancermetastasisbytargetingextracellularsignalregulatedkinaseanetworkpharmacologystudy